Rationale and protocol of a trial for prevention of diabetic atherosclerosis by using antiplatelet drugs: study of Diabetic Atherosclerosis Prevention by Cilostazol (DAPC study)

BACKGROUND: Secondary treatment of arteriosclerosis may be applicable for the primary prevention of atherosclerosis in diabetic patients. This prospective, 2-year follow-up study was designed to determine the efficacy and safety of antiplatelet therapy in the prevention of atherosclerosis of diabeti...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamasaki, Yoshimitsu, Kim, Young-Seol, Kawamori, Ryuzo
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574287/
https://www.ncbi.nlm.nih.gov/pubmed/16925808
http://dx.doi.org/10.1186/1475-2840-5-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574287/
https://www.ncbi.nlm.nih.gov/pubmed/16925808
http://dx.doi.org/10.1186/1475-2840-5-16

Ejemplares similares